Cash Flow Mabpharm Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
4.00
-138.00
-231.00
-245.00
-351.00
-207.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3.00
37.00
200.00
95.00
34.00
-29.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
81.00
-8.00
59.00
-67.00
-240.00
-155.00
Cash Flow from Investing Activities
-70.00
-64.00
-4.00
-122.00
-218.00
160.00
Cash Flow from Financing Activities
10.00
24.00
98.00
132.00
-18.00
-85.00
Net Cash Inflow / Outflow
21.00
-48.00
154.00
-55.00
-486.00
-116.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
1.00
-7.00
-36.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mabpharm Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
4.51161722220612
971.420261808436
-967.00
-99.54%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3.71557706809572
-43.6340404003642
40.00
91.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
81.3772111221722
1764.86770822627
-1,683.00
-95.39%
Cash Flow from Investing Activities
-70.0504490383451
-941.941601552825
871.00
92.56%
Cash Flow from Financing Activities
10.271520844114
-1209.9400393308
1,219.00
100.85%
Net Cash Inflow / Outflow
21.5971984045704
-387.688719304451
408.00
105.57%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.0010845233707226
-0.6747866470837
0.00
99.84%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 1,025.36% vs -114.70% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
81.38
-8.79
1,025.36%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
